Naloxone Spray Market By Distribution Channel (emergency departments, hospitals, clinics, retail pharmacies, online, others), By Dosage Form (2 mg/actuation, 4 mg/actuation, others), By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-274 | Category : Healthcare | Published Date : September, 2019 | Pages : 150 | Format :PDF

Industry Trends

Global naloxone spray market was valued at US$ 208.95 million in 2018 and is expected to reach US$ 1,043.65 million by 2027, growing at an estimated CAGR of 19.7% over the forecast period. Increasing government initiatives to promote naloxone spray to reduce usage of opioids in the form of painkillers is expected to drive the growth of naloxone spray market.

Naloxone is an antagonist used to reduce the effects of opioids overdose. It is sold under Narcan, Evzio and other brand names. Increased usage of prescription opioids and non-prescription opioids as painkillers has amplified the addiction. Naloxone is majorly used to reverse effects of opioid medicines for a short time period. Governments of various countries such as United States and the UK amongst others are increasing their investments and initiatives to reduce usage of opioids, since, large number of people are being adversely affected due to over dosage of opioids. In several countries including United Sates, government has approved naloxone spray for public use and it is available over the counter. Naloxone only works on limited opioids like fentanyl, heroin, morphine and codeine, and mixed agonist may require high dose of naloxone. But, there are concerns regarding side effects caused due to usage of naloxone spray, like flushing, nausea, dizziness and body aches amongst others. Its severe side effects may also include agitation, high or low blood pressure, shortness of breath and cardiac arrhythmias. Online sales accounts for a significant share of naloxone spray market as this product is readily available through various online platforms. Based on dosage, form 2 mg/actuation is more preferred as compared to 4 mg/actuation. The dosage can be increased by number of spray in each nostril depending upon patients’ age group. Geographically, North America holds the largest market share of naloxone spray market. FDA of United States approved the naloxone spray for public use and it is available through multiple distribution channels in the region. In Europe, countries like the UK approved naloxone spray and in many countries, the approval is under process. As more countries grant approval for the product, the market would be impacted positively over the forecast period.

Competitive Landscape

The report provides both, qualitative and quantitative research of naloxone spray market, as well as provides comprehensive insights and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings, specification, pricing, and gross margin.

Some of the key players which are operating in the naloxone spray market are Teva Pharmaceutical Industries Ltd., Emergent BioSolutions Inc.

Click on image to enlarge

Naloxone Spray Market:

By Distribution Channel
- Emergency Departments
- Hospitals
- Clinics
- Retail Pharmacies
- Online
- Others
By Dosage Form
- 2 mg/actuation
- 4 mg/actuation
By Geography
- North America
  - U.S.
  - Canada
  - Mexico
  - Rest of North America
- Europe
  - France
  - The UK
  - Spain
  - Germany
  - Italy
  - Nordic Countries
    - Denmark
    - Finland
    - Iceland
    - Norway
    - Sweden
  - Benelux Union
    - Belgium
    - The Netherlands
    - Luxemburg
    - Rest of Europe
  - Asia Pacific
    - China
    - Japan
    - India
    - New Zealand
    - Australia
    - South Korea
    - Southeast Asia
      - Indonesia
      - Thailand
      - Malaysia
      - Singapore
      - Rest of Southeast Asia
    - Rest of Asia Pacific
  - Middle East & Africa
    - Saudi Arabia
    - UAE
    - Egypt
    - Kuwait
    - South Africa
    - Rest of Middle East & Africa
  - Latin America
    - Brazil
    - Argentina
    - Rest of Latin America

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Base Year: 2018

1.2.2. Forecast Years: 2019 – 2027

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Naloxone Spray Market

6. Market Synopsis: Naloxone Spray Market

7. Naloxone Spray Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in Naloxone Spray Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Naloxone Spray Market

7.6. Porter’s Five Force Analysis

8. Global Naloxone Spray Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Naloxone Spray Market Revenue (US$ Mn)

8.2. Global Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

8.2.1. Emergency Departments

8.2.1.1. Definition

8.2.1.2. Market Penetration, 2018

8.2.1.3. Market Forecast, 2019 – 2027

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2018

8.2.1.5.1.2. Market Forecast, 2019 – 2027

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2018

8.2.1.5.2.2. Market Forecast, 2019 – 2027

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2018

8.2.1.5.3.2. Market Forecast, 2019 – 2027

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2018

8.2.1.5.4.2. Market Forecast, 2019 – 2027

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2018

8.2.1.5.5.2. Market Forecast, 2019 – 2027

8.2.2. Hospitals

8.2.2.1. Definition

8.2.2.2. Market Penetration, 2018

8.2.2.3. Market Forecast, 2019 – 2027

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2018

8.2.2.5.1.2. Market Forecast, 2019 – 2027

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2018

8.2.2.5.2.2. Market Forecast, 2019 – 2027

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2018

8.2.2.5.3.2. Market Forecast, 2019 – 2027

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2018

8.2.2.5.4.2. Market Forecast, 2019 – 2027

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2018

8.2.2.5.5.2. Market Forecast, 2019 – 2027

8.2.3. Clinics

8.2.3.1. Definition

8.2.3.2. Market Penetration, 2018

8.2.3.3. Market Forecast, 2019 – 2027

8.2.3.4. Compound Annual Growth Rate (CAGR)

8.2.3.5. Regional Bifurcation

8.2.3.5.1. North America

8.2.3.5.1.1. Market Estimation, 2018

8.2.3.5.1.2. Market Forecast, 2019 – 2027

8.2.3.5.2. Europe

8.2.3.5.2.1. Market Estimation, 2018

8.2.3.5.2.2. Market Forecast, 2019 – 2027

8.2.3.5.3. Asia Pacific

8.2.3.5.3.1. Market Estimation, 2018

8.2.3.5.3.2. Market Forecast, 2019 – 2027

8.2.3.5.4. Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2018

8.2.3.5.4.2. Market Forecast, 2019 – 2027

8.2.3.5.5. Latin America

8.2.3.5.5.1. Market Estimation, 2018

8.2.3.5.5.2. Market Forecast, 2019 – 2027

8.2.4. Retail Pharmacies

8.2.4.1. Definition

8.2.4.2. Market Penetration, 2018

8.2.4.3. Market Forecast, 2019 – 2027

8.2.4.4. Compound Annual Growth Rate (CAGR)

8.2.4.5. Regional Bifurcation

8.2.4.5.1. North America

8.2.4.5.1.1. Market Estimation, 2018

8.2.4.5.1.2. Market Forecast, 2019 – 2027

8.2.4.5.2. Europe

8.2.4.5.2.1. Market Estimation, 2018

8.2.4.5.2.2. Market Forecast, 2019 – 2027

8.2.4.5.3. Asia Pacific

8.2.4.5.3.1. Market Estimation, 2018

8.2.4.5.3.2. Market Forecast, 2019 – 2027

8.2.4.5.4. Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2018

8.2.4.5.4.2. Market Forecast, 2019 – 2027

8.2.4.5.5. Latin America

8.2.4.5.5.1. Market Estimation, 2018

8.2.4.5.5.2. Market Forecast, 2019 – 2027

8.2.5. Online

8.2.5.1. Definition

8.2.5.2. Market Penetration, 2018

8.2.5.3. Market Forecast, 2019 – 2027

8.2.5.4. Compound Annual Growth Rate (CAGR)

8.2.5.5. Regional Bifurcation

8.2.5.5.1. North America

8.2.5.5.1.1. Market Estimation, 2018

8.2.5.5.1.2. Market Forecast, 2019 – 2027

8.2.5.5.2. Europe

8.2.5.5.2.1. Market Estimation, 2018

8.2.5.5.2.2. Market Forecast, 2019 – 2027

8.2.5.5.3. Asia Pacific

8.2.5.5.3.1. Market Estimation, 2018

8.2.5.5.3.2. Market Forecast, 2019 – 2027

8.2.5.5.4. Middle East and Africa

8.2.5.5.4.1. Market Estimation, 2018

8.2.5.5.4.2. Market Forecast, 2019 – 2027

8.2.5.5.5. Latin America

8.2.5.5.5.1. Market Estimation, 2018

8.2.5.5.5.2. Market Forecast, 2019 – 2027

8.2.6. Others

8.2.6.1. Definition

8.2.6.2. Market Penetration, 2018

8.2.6.3. Market Forecast, 2019 – 2027

8.2.6.4. Compound Annual Growth Rate (CAGR)

8.2.6.5. Regional Bifurcation

8.2.6.5.1. North America

8.2.6.5.1.1. Market Estimation, 2018

8.2.6.5.1.2. Market Forecast, 2019 – 2027

8.2.6.5.2. Europe

8.2.6.5.2.1. Market Estimation, 2018

8.2.6.5.2.2. Market Forecast, 2019 – 2027

8.2.6.5.3. Asia Pacific

8.2.6.5.3.1. Market Estimation, 2018

8.2.6.5.3.2. Market Forecast, 2019 – 2027

8.2.6.5.4. Middle East and Africa

8.2.6.5.4.1. Market Estimation, 2018

8.2.6.5.4.2. Market Forecast, 2019 – 2027

8.2.6.5.5. Latin America

8.2.6.5.5.1. Market Estimation, 2018

8.2.6.5.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Distribution Channel

9. Global Naloxone Spray Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

9.2.1. 2 mg/actuation

9.2.1.1. Definition

9.2.1.2. Market Penetration, 2018

9.2.1.3. Market Forecast, 2019 – 2027

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2018

9.2.1.5.1.2. Market Forecast, 2019 – 2027

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2018

9.2.1.5.2.2. Market Forecast, 2019 – 2027

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2018

9.2.1.5.3.2. Market Forecast, 2019 – 2027

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2018

9.2.1.5.4.2. Market Forecast, 2019 – 2027

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2018

9.2.1.5.5.2. Market Forecast, 2019 – 2027

9.2.2. 4 mg/actuation

9.2.2.1. Definition

9.2.2.2. Market Penetration, 2018

9.2.2.3. Market Forecast, 2019 – 2027

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2018

9.2.2.5.1.2. Market Forecast, 2019 – 2027

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2018

9.2.2.5.2.2. Market Forecast, 2019 – 2027

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2018

9.2.2.5.3.2. Market Forecast, 2019 – 2027

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2018

9.2.2.5.4.2. Market Forecast, 2019 – 2027

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2018

9.2.2.5.5.2. Market Forecast, 2019 – 2027

9.2.3. Others

9.2.3.1. Definition

9.2.3.2. Market Penetration, 2018

9.2.3.3. Market Forecast, 2019 – 2027

9.2.3.4. Compound Annual Growth Rate (CAGR)

9.2.3.5. Regional Bifurcation

9.2.3.5.1. North America

9.2.3.5.1.1. Market Estimation, 2018

9.2.3.5.1.2. Market Forecast, 2019 – 2027

9.2.3.5.2. Europe

9.2.3.5.2.1. Market Estimation, 2018

9.2.3.5.2.2. Market Forecast, 2019 – 2027

9.2.3.5.3. Asia Pacific

9.2.3.5.3.1. Market Estimation, 2018

9.2.3.5.3.2. Market Forecast, 2019 – 2027

9.2.3.5.4. Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2018

9.2.3.5.4.2. Market Forecast, 2019 – 2027

9.2.3.5.5. Latin America

9.2.3.5.5.1. Market Estimation, 2018

9.2.3.5.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Dosage Form

10. North America Naloxone Spray Market Analysis and Forecasts, 2019 - 2027

10.1. Overview

10.1.1. North America Naloxone Spray Market Revenue (US$ Mn)

10.2. North America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

10.2.1. Emergency Departments

10.2.2. Hospitals

10.2.3. Clinics

10.2.4. Retail Pharmacies

10.2.5. Online

10.2.6. Others

10.3. North America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

10.3.1. 2 mg/actuation

10.3.2. 4 mg/actuation

10.3.3. Others

10.4. North America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Country

10.4.1. U.S

10.4.1.1. U.S Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

10.4.1.1.1. Emergency Departments

10.4.1.1.2. Hospitals

10.4.1.1.3. Clinics

10.4.1.1.4. Retail Pharmacies

10.4.1.1.5. Online

10.4.1.1.6. Others

10.4.1.2. U.S Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

10.4.1.2.1. 2 mg/actuation

10.4.1.2.2. 4 mg/actuation

10.4.1.2.3. Others

10.4.2. Canada

10.4.2.1. Canada Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

10.4.2.1.1. Emergency Departments

10.4.2.1.2. Hospitals

10.4.2.1.3. Clinics

10.4.2.1.4. Retail Pharmacies

10.4.2.1.5. Online

10.4.2.1.6. Others

10.4.2.2. Canada Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

10.4.2.2.1. 2 mg/actuation

10.4.2.2.2. 4 mg/actuation

10.4.2.2.3. Others

10.4.3. Mexico

10.4.3.1. Mexico Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

10.4.3.1.1. Emergency Departments

10.4.3.1.2. Hospitals

10.4.3.1.3. Clinics

10.4.3.1.4. Retail Pharmacies

10.4.3.1.5. Online

10.4.3.1.6. Others

10.4.3.2. Mexico Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

10.4.3.2.1. 2 mg/actuation

10.4.3.2.2. 4 mg/actuation

10.4.3.2.3. Others

10.4.4. Rest of North America

10.4.4.1. Rest of North America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

10.4.4.1.1. Emergency Departments

10.4.4.1.2. Hospitals

10.4.4.1.3. Clinics

10.4.4.1.4. Retail Pharmacies

10.4.4.1.5. Online

10.4.4.1.6. Others

10.4.4.2. Rest of North America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

10.4.4.2.1. 2 mg/actuation

10.4.4.2.2. 4 mg/actuation

10.4.4.2.3. Others

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Distribution Channel

10.5.3. By Dosage Form

11. Europe Naloxone Spray Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. Europe Naloxone Spray Market Revenue (US$ Mn)

11.2. Europe Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.2.1. Emergency Departments

11.2.2. Hospitals

11.2.3. Clinics

11.2.4. Retail Pharmacies

11.2.5. Online

11.2.6. Others

11.3. Europe Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.3.1. 2 mg/actuation

11.3.2. 4 mg/actuation

11.3.3. Others

11.4. Europe Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Country

11.4.1. France

11.4.1.1. France Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.4.1.1.1. Emergency Departments

11.4.1.1.2. Hospitals

11.4.1.1.3. Clinics

11.4.1.1.4. Retail Pharmacies

11.4.1.1.5. Online

11.4.1.1.6. Others

11.4.1.2. France Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.4.1.2.1. 2 mg/actuation

11.4.1.2.2. 4 mg/actuation

11.4.1.2.3. Others

11.4.2. The UK

11.4.2.1. The UK Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.4.2.1.1. Emergency Departments

11.4.2.1.2. Hospitals

11.4.2.1.3. Clinics

11.4.2.1.4. Retail Pharmacies

11.4.2.1.5. Online

11.4.2.1.6. Others

11.4.2.2. The UK Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.4.2.2.1. 2 mg/actuation

11.4.2.2.2. 4 mg/actuation

11.4.2.2.3. Others

11.4.3. Spain

11.4.3.1. Spain Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.4.3.1.1. Emergency Departments

11.4.3.1.2. Hospitals

11.4.3.1.3. Clinics

11.4.3.1.4. Retail Pharmacies

11.4.3.1.5. Online

11.4.3.1.6. Others

11.4.3.2. Spain Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.4.3.2.1. 2 mg/actuation

11.4.3.2.2. 4 mg/actuation

11.4.3.2.3. Others

11.4.4. Germany

11.4.4.1. Germany Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.4.4.1.1. Emergency Departments

11.4.4.1.2. Hospitals

11.4.4.1.3. Clinics

11.4.4.1.4. Retail Pharmacies

11.4.4.1.5. Online

11.4.4.1.6. Others

11.4.4.2. Germany Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.4.4.2.1. 2 mg/actuation

11.4.4.2.2. 4 mg/actuation

11.4.4.2.3. Others

11.4.5. Italy

11.4.5.1. Italy Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.4.5.1.1. Emergency Departments

11.4.5.1.2. Hospitals

11.4.5.1.3. Clinics

11.4.5.1.4. Retail Pharmacies

11.4.5.1.5. Online

11.4.5.1.6. Others

11.4.5.2. Italy Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.4.5.2.1. 2 mg/actuation

11.4.5.2.2. 4 mg/actuation

11.4.5.2.3. Others

11.4.6. Nordic Countries

11.4.6.1. Nordic Countries Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.4.6.1.1. Emergency Departments

11.4.6.1.2. Hospitals

11.4.6.1.3. Clinics

11.4.6.1.4. Retail Pharmacies

11.4.6.1.5. Online

11.4.6.1.6. Others

11.4.6.2. Nordic Countries Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.4.6.2.1. 2 mg/actuation

11.4.6.2.2. 4 mg/actuation

11.4.6.2.3. Others

11.4.6.3. Nordic Countries Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Country

11.4.6.3.1. Denmark

11.4.6.3.2. Finland

11.4.6.3.3. Iceland

11.4.6.3.4. Sweden

11.4.6.3.5. Norway

11.4.7. Benelux Union

11.4.7.1. Benelux Union Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.4.7.1.1. Emergency Departments

11.4.7.1.2. Hospitals

11.4.7.1.3. Clinics

11.4.7.1.4. Retail Pharmacies

11.4.7.1.5. Online

11.4.7.1.6. Others

11.4.7.2. Benelux Union Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.4.7.2.1. 2 mg/actuation

11.4.7.2.2. 4 mg/actuation

11.4.7.2.3. Others

11.4.7.3. Benelux Union Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Country

11.4.7.3.1. Belgium

11.4.7.3.2. The Netherlands

11.4.7.3.3. Luxembourg

11.4.8. Rest of Europe

11.4.8.1. Rest of Europe Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.4.8.1.1. Emergency Departments

11.4.8.1.2. Hospitals

11.4.8.1.3. Clinics

11.4.8.1.4. Retail Pharmacies

11.4.8.1.5. Online

11.4.8.1.6. Others

11.4.8.2. Rest of Europe Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

11.4.8.2.1. 2 mg/actuation

11.4.8.2.2. 4 mg/actuation

11.4.8.2.3. Others

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Distribution Channel

11.5.3. By Dosage Form

12. Asia Pacific Naloxone Spray Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. Asia Pacific Naloxone Spray Market Revenue (US$ Mn)

12.2. Asia Pacific Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.2.1. Emergency Departments

12.2.2. Hospitals

12.2.3. Clinics

12.2.4. Retail Pharmacies

12.2.5. Online

12.2.6. Others

12.3. Asia Pacific Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.3.1. 2 mg/actuation

12.3.2. 4 mg/actuation

12.3.3. Others

12.4. Asia Pacific Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Country

12.4.1. China

12.4.1.1. China Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.1.1.1. Emergency Departments

12.4.1.1.2. Hospitals

12.4.1.1.3. Clinics

12.4.1.1.4. Retail Pharmacies

12.4.1.1.5. Online

12.4.1.1.6. Others

12.4.1.2. China Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.4.1.2.1. 2 mg/actuation

12.4.1.2.2. 4 mg/actuation

12.4.1.2.3. Others

12.4.2. Japan

12.4.2.1. Japan Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.2.1.1. Emergency Departments

12.4.2.1.2. Hospitals

12.4.2.1.3. Clinics

12.4.2.1.4. Retail Pharmacies

12.4.2.1.5. Online

12.4.2.1.6. Others

12.4.2.2. Japan Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.4.2.2.1. 2 mg/actuation

12.4.2.2.2. 4 mg/actuation

12.4.2.2.3. Others

12.4.3. India

12.4.3.1. India Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.3.1.1. Emergency Departments

12.4.3.1.2. Hospitals

12.4.3.1.3. Clinics

12.4.3.1.4. Retail Pharmacies

12.4.3.1.5. Online

12.4.3.1.6. Others

12.4.3.2. India Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.4.3.2.1. 2 mg/actuation

12.4.3.2.2. 4 mg/actuation

12.4.3.2.3. Others

12.4.4. New Zealand

12.4.4.1. New Zealand Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.4.1.1. Emergency Departments

12.4.4.1.2. Hospitals

12.4.4.1.3. Clinics

12.4.4.1.4. Retail Pharmacies

12.4.4.1.5. Online

12.4.4.1.6. Others

12.4.4.2. New Zealand Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.4.4.2.1. 2 mg/actuation

12.4.4.2.2. 4 mg/actuation

12.4.4.2.3. Others

12.4.5. Australia

12.4.5.1. Australia Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.5.1.1. Emergency Departments

12.4.5.1.2. Hospitals

12.4.5.1.3. Clinics

12.4.5.1.4. Retail Pharmacies

12.4.5.1.5. Online

12.4.5.1.6. Others

12.4.5.2. Australia Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.4.5.2.1. 2 mg/actuation

12.4.5.2.2. 4 mg/actuation

12.4.5.2.3. Others

12.4.6. South Korea

12.4.6.1. South Korea Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.6.1.1. Emergency Departments

12.4.6.1.2. Hospitals

12.4.6.1.3. Clinics

12.4.6.1.4. Retail Pharmacies

12.4.6.1.5. Online

12.4.6.1.6. Others

12.4.6.2. South Korea Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.4.6.2.1. 2 mg/actuation

12.4.6.2.2. 4 mg/actuation

12.4.6.2.3. Others

12.4.7. Southeast Asia

12.4.7.1. Southeast Asia Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.7.1.1. Emergency Departments

12.4.7.1.2. Hospitals

12.4.7.1.3. Clinics

12.4.7.1.4. Retail Pharmacies

12.4.7.1.5. Online

12.4.7.1.6. Others

12.4.7.2. Southeast Asia Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.4.7.2.1. 2 mg/actuation

12.4.7.2.2. 4 mg/actuation

12.4.7.2.3. Others

12.4.7.3. Southeast Asia Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Country

12.4.7.3.1. Indonesia

12.4.7.3.2. Thailand

12.4.7.3.3. Malaysia

12.4.7.3.4. Singapore

12.4.7.3.5. Rest of Southeast Asia

12.4.8. Rest of Asia Pacific

12.4.8.1. Rest of Asia Pacific Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.8.1.1. Emergency Departments

12.4.8.1.2. Hospitals

12.4.8.1.3. Clinics

12.4.8.1.4. Retail Pharmacies

12.4.8.1.5. Online

12.4.8.1.6. Others

12.4.8.2. Rest of Asia Pacific Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

12.4.8.2.1. 2 mg/actuation

12.4.8.2.2. 4 mg/actuation

12.4.8.2.3. Others

12.5. Key Segment for Channeling Investments

12.5.1. By Country

12.5.2. By Distribution Channel

12.5.3. By Dosage Form

13. Middle East and Africa Naloxone Spray Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Middle East and Africa Naloxone Spray Market Revenue (US$ Mn)

13.2. Middle East and Africa Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.2.1. Emergency Departments

13.2.2. Hospitals

13.2.3. Clinics

13.2.4. Retail Pharmacies

13.2.5. Online

13.2.6. Others

13.3. Middle East and Africa Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

13.3.1. 2 mg/actuation

13.3.2. 4 mg/actuation

13.3.3. Others

13.4. Middle East and Africa Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Country

13.4.1. Saudi Arabia

13.4.1.1. Saudi Arabia Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.4.1.1.1. Emergency Departments

13.4.1.1.2. Hospitals

13.4.1.1.3. Clinics

13.4.1.1.4. Retail Pharmacies

13.4.1.1.5. Online

13.4.1.1.6. Others

13.4.1.2. Saudi Arabia Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

13.4.1.2.1. 2 mg/actuation

13.4.1.2.2. 4 mg/actuation

13.4.1.2.3. Others

13.4.2. UAE

13.4.2.1. UAE Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.4.2.1.1. Emergency Departments

13.4.2.1.2. Hospitals

13.4.2.1.3. Clinics

13.4.2.1.4. Retail Pharmacies

13.4.2.1.5. Online

13.4.2.1.6. Others

13.4.2.2. UAE Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

13.4.2.2.1. 2 mg/actuation

13.4.2.2.2. 4 mg/actuation

13.4.2.2.3. Others

13.4.3. Egypt

13.4.3.1. Egypt Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.4.3.1.1. Emergency Departments

13.4.3.1.2. Hospitals

13.4.3.1.3. Clinics

13.4.3.1.4. Retail Pharmacies

13.4.3.1.5. Online

13.4.3.1.6. Others

13.4.3.2. Egypt Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

13.4.3.2.1. 2 mg/actuation

13.4.3.2.2. 4 mg/actuation

13.4.3.2.3. Others

13.4.4. Kuwait

13.4.4.1. Kuwait Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.4.4.1.1. Emergency Departments

13.4.4.1.2. Hospitals

13.4.4.1.3. Clinics

13.4.4.1.4. Retail Pharmacies

13.4.4.1.5. Online

13.4.4.1.6. Others

13.4.4.2. Kuwait Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

13.4.4.2.1. 2 mg/actuation

13.4.4.2.2. 4 mg/actuation

13.4.4.2.3. Others

13.4.5. South Africa

13.4.5.1. South Africa Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.4.5.1.1. Emergency Departments

13.4.5.1.2. Hospitals

13.4.5.1.3. Clinics

13.4.5.1.4. Retail Pharmacies

13.4.5.1.5. Online

13.4.5.1.6. Others

13.4.5.2. South Africa Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

13.4.5.2.1. 2 mg/actuation

13.4.5.2.2. 4 mg/actuation

13.4.5.2.3. Others

13.4.6. Rest of Middle East & Africa

13.4.6.1. Rest of Middle East & Africa Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.4.6.1.1. Emergency Departments

13.4.6.1.2. Hospitals

13.4.6.1.3. Clinics

13.4.6.1.4. Retail Pharmacies

13.4.6.1.5. Online

13.4.6.1.6. Others

13.4.6.2. Rest of Middle East & Africa Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

13.4.6.2.1. 2 mg/actuation

13.4.6.2.2. 4 mg/actuation

13.4.6.2.3. Others

13.5. Key Segment for Channeling Investments

13.5.1. By Country

13.5.2. By Distribution Channel

13.5.3. By Dosage Form

14. Latin America Naloxone Spray Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Latin America Naloxone Spray Market Revenue (US$ Mn)

14.2. Latin America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.2.1. Emergency Departments

14.2.2. Hospitals

14.2.3. Clinics

14.2.4. Retail Pharmacies

14.2.5. Online

14.2.6. Others

14.3. Latin America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

14.3.1. 2 mg/actuation

14.3.2. 4 mg/actuation

14.3.3. Others

14.4. Latin America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Country

14.4.1. Brazil

14.4.1.1. Brazil Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.4.1.1.1. Emergency Departments

14.4.1.1.2. Hospitals

14.4.1.1.3. Clinics

14.4.1.1.4. Retail Pharmacies

14.4.1.1.5. Online

14.4.1.1.6. Others

14.4.1.2. Brazil Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

14.4.1.2.1. 2 mg/actuation

14.4.1.2.2. 4 mg/actuation

14.4.1.2.3. Others

14.4.2. Argentina

14.4.2.1. Argentina Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.4.2.1.1. Emergency Departments

14.4.2.1.2. Hospitals

14.4.2.1.3. Clinics

14.4.2.1.4. Retail Pharmacies

14.4.2.1.5. Online

14.4.2.1.6. Others

14.4.2.2. Argentina Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

14.4.2.2.1. 2 mg/actuation

14.4.2.2.2. 4 mg/actuation

14.4.2.2.3. Others

14.4.3. Rest of Latin America

14.4.3.1. Rest of Latin America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.4.3.1.1. Emergency Departments

14.4.3.1.2. Hospitals

14.4.3.1.3. Clinics

14.4.3.1.4. Retail Pharmacies

14.4.3.1.5. Online

14.4.3.1.6. Others

14.4.3.2. Rest of Latin America Naloxone Spray Market Revenue (US$ Mn) and Forecasts, By Dosage Form

14.4.3.2.1. 2 mg/actuation

14.4.3.2.2. 4 mg/actuation

14.4.3.2.3. Others

14.5. Key Segment for Channeling Investments

14.5.1. By Country

14.5.2. By Distribution Channel

14.5.3. By Dosage Form

15. Competitive Benchmarking

15.1. Market Share Analysis, 2018

15.2. Global Presence and Growth Strategies

15.2.1. Mergers and Acquisitions

15.2.2. Product Launches

15.2.3. Investments Trends

15.2.4. R&D Initiatives

16. Player Profiles

16.1. Emergent BioSolutions Inc.

16.1.1. Company Details

16.1.2. Company Overview

16.1.3. Product Offerings

16.1.4. Key Developments

16.1.5. Financial Analysis

16.1.6. SWOT Analysis

16.1.7. Business Strategies

16.2. Pfizer Inc.

16.2.1. Company Details

16.2.2. Company Overview

16.2.3. Product Offerings

16.2.4. Key Developments

16.2.5. Financial Analysis

16.2.6. SWOT Analysis

16.2.7. Business Strategies

16.3. Teva Pharmaceutical Industries Ltd.

16.3.1. Company Details

16.3.2. Company Overview

16.3.3. Product Offerings

16.3.4. Key Developments

16.3.5. Financial Analysis

16.3.6. SWOT Analysis

16.3.7. Business Strategies

16.4. Other Market Participants

17. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources: